Axogen, Inc. (AXGN) income statement
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30152% above fair value
$56.95+1.58 (+2.85%)
Close on Nov 18, 2026Market cap $3.40BP/E –Yield –
Axogen, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 74.2%
- Operating margin
- -5.2%
- Net margin
- -12.0%
- Return on equity, FY2025
- -13.5%
Financial strength
- Current ratio
- 12.02
- Debt to equity
- 0.00
- Debt to assets
- 0.0%
- Cash to current liabilities
- 902.2%
Valuation
- P/E ratio
- –
- Price to sales
- 12.74
- Price to book
- 6.86
- Dividend yield
- –
See a number that looks wrong?